Principal Technologies Inc.

Biotech Vancouver, A1

About

Issuer

Entity type
Corporation
Jurisdiction
British Columbia, Canada
Sector
Biotech
Headquarters
Vancouver, A1
Street
2500 - 700 West Georgia Street
Zip
V7Y 1B3

Offering

Total offering
$325k
Amount sold
$325k
First sale
Dec 15, 2025
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
2

How this filing compares

Ranked #41 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.1× the median.

Other A1 filings this week: FENDX TECHNOLOGIES INC., K2 Gold Corp, AERO ENERGY Ltd, Azarga Metals Corp., Great Pacific Gold Corp.

Leadership

Gerald Trent — Executive Officer (also: Director)

Peter McKeown — Executive Officer

Alfred Von Liechtenstein — Director

Leopold Specht — Director

Filing details

Principal Technologies Inc. filed a Form D with the SEC on April 16, 2026.

Other newest Biotech companies

Other newest companies in A1